<html xmlns:v="urn:schemas-microsoft-com:vml" xmlns:o="urn:schemas-microsoft-com:office:office" xmlns:w="urn:schemas-microsoft-com:office:word" xmlns:m="http://schemas.microsoft.com/office/2004/12/omml" xmlns="http://www.w3.org/TR/REC-html40">
<head>
<meta http-equiv="Content-Type" content="text/html; charset=us-ascii">
<meta name="Generator" content="Microsoft Word 15 (filtered medium)">
<style><!--
/* Font Definitions */
@font-face
{font-family:"Cambria Math";
panose-1:2 4 5 3 5 4 6 3 2 4;}
@font-face
{font-family:Calibri;
panose-1:2 15 5 2 2 2 4 3 2 4;}
/* Style Definitions */
p.MsoNormal, li.MsoNormal, div.MsoNormal
{margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
a:link, span.MsoHyperlink
{mso-style-priority:99;
color:blue;
text-decoration:underline;}
a:visited, span.MsoHyperlinkFollowed
{mso-style-priority:99;
color:purple;
text-decoration:underline;}
p.msonormal0, li.msonormal0, div.msonormal0
{mso-style-name:msonormal;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.xmsonormal, li.xmsonormal, div.xmsonormal
{mso-style-name:x_msonormal;
margin:0cm;
margin-bottom:.0001pt;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
p.xmsolistparagraph, li.xmsolistparagraph, div.xmsolistparagraph
{mso-style-name:x_msolistparagraph;
mso-margin-top-alt:auto;
margin-right:0cm;
mso-margin-bottom-alt:auto;
margin-left:0cm;
font-size:11.0pt;
font-family:"Calibri",sans-serif;}
span.EmailStyle20
{mso-style-type:personal;
font-family:"Arial",sans-serif;
color:windowtext;
font-weight:normal;
font-style:normal;
text-decoration:none none;}
span.EmailStyle21
{mso-style-type:personal-reply;
font-family:"Calibri",sans-serif;
color:windowtext;}
.MsoChpDefault
{mso-style-type:export-only;
font-size:10.0pt;}
@page WordSection1
{size:612.0pt 792.0pt;
margin:72.0pt 72.0pt 72.0pt 72.0pt;}
div.WordSection1
{page:WordSection1;}
/* List Definitions */
@list l0
{mso-list-id:193419573;
mso-list-template-ids:661445840;}
@list l0:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level2
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:72.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level3
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:108.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:144.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level5
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:180.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level6
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:216.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:252.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level8
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:288.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l0:level9
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:324.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1
{mso-list-id:416441381;
mso-list-template-ids:1913443416;}
@list l1:level1
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:36.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level2
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:72.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level3
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:108.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level4
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:144.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level5
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:180.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level6
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:216.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level7
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:252.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level8
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:288.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
@list l1:level9
{mso-level-number-format:bullet;
mso-level-text:\F0B7;
mso-level-tab-stop:324.0pt;
mso-level-number-position:left;
text-indent:-18.0pt;
mso-ansi-font-size:10.0pt;
font-family:Symbol;}
ol
{margin-bottom:0cm;}
ul
{margin-bottom:0cm;}
--></style><!--[if gte mso 9]><xml>
<o:shapedefaults v:ext="edit" spidmax="1026" />
</xml><![endif]--><!--[if gte mso 9]><xml>
<o:shapelayout v:ext="edit">
<o:idmap v:ext="edit" data="1" />
</o:shapelayout></xml><![endif]-->
</head>
<body lang="EN-GB" link="blue" vlink="purple">
<div class="WordSection1">
<p class="MsoNormal"><b><span lang="EN-US">Message sent on behalf of Gail McConnell<o:p></o:p></span></b></p>
<p class="MsoNormal"><o:p> </o:p></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">Dear all,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif;color:black">Please see
</span><span style="font-size:10.0pt;font-family:"Arial",sans-serif">the <span style="color:black">
call below to apply to attend a sandpit workshop to develop research applications for technological innovations for understanding of cancers of unmet need.<o:p></o:p></span></span></p>
<div>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">Thanks,<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">G.<o:p></o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif"><o:p> </o:p></span></p>
<p class="MsoNormal"><span style="font-size:10.0pt;font-family:"Arial",sans-serif">--<o:p></o:p></span></p>
</div>
<div>
<div>
<div>
<p class="xmsonormal"><o:p> </o:p></p>
<p class="xmsonormal"><o:p> </o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif">We are delighted to let you know that the funding opportunity:
</span><a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.ukri.org%2Fopportunity%2Ftechnological-innovation-for-understanding-cancers-of-unmet-need%2F&data=05%7C01%7Ccath.cheshire%40strath.ac.uk%7C5a6c2280781e482273d108daac3ec8d3%7C631e0763153347eba5cd0457bee5944e%7C0%7C0%7C638011682890378441%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=mzhFLbjZtg8wmpR2YHNz0dOtjUv2JV95NlH7Jj%2BPc7c%3D&reserved=0"><span style="font-family:"Arial",sans-serif">Technological
innovation for understanding cancers of unmet need – sandpit workshop</span></a><span style="font-family:"Arial",sans-serif"> is now live and open to applications to attend.
<b>We would be grateful if you could circulate the announcement to relevant members of your communities.</b></span><o:p></o:p></p>
<p class="xmsonormal"><b><span style="font-family:"Arial",sans-serif"> </span></b><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif"> </span><o:p></o:p></p>
<p class="xmsonormal"><b><span style="font-family:"Arial",sans-serif"><a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.ukri.org%2Fopportunity%2Ftechnological-innovation-for-understanding-cancers-of-unmet-need%2F&data=05%7C01%7Ccath.cheshire%40strath.ac.uk%7C5a6c2280781e482273d108daac3ec8d3%7C631e0763153347eba5cd0457bee5944e%7C0%7C0%7C638011682890378441%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=mzhFLbjZtg8wmpR2YHNz0dOtjUv2JV95NlH7Jj%2BPc7c%3D&reserved=0">Technological
innovation for understanding cancers of unmet need – sandpit workshop</a></span></b><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif"> </span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif">This initiative aims to bring together
<b>researchers from diverse disciplines, such as medical, data, engineering and physical sciences</b>, to drive co-development of innovative and high-risk high-reward technologies to understand cancers of unmet need better and to treat cancer more effectively.
</span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif"> </span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif">The focus will be on
<b>hard-to-treat cancers</b>, including brain, lung, oesophageal, pancreatic, stomach and liver cancers, which have some of the poorest 5-year survival figures.
</span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif"> </span><o:p></o:p></p>
<p class="xmsonormal"><b><span style="font-family:"Arial",sans-serif">Cancer challenge themes</span></b><span style="font-family:"Arial",sans-serif"> we aim to consider include:
</span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif"> </span><o:p></o:p></p>
<ul style="margin-top:0cm" type="disc">
<li class="xmsolistparagraph" style="margin-top:0cm;margin-bottom:0cm;margin-bottom:.0001pt;line-height:115%;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">hard to access cancers</span><o:p></o:p></li><li class="xmsolistparagraph" style="margin-top:0cm;margin-bottom:0cm;margin-bottom:.0001pt;line-height:115%;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">tumour heterogeneity and molecular complexity</span><o:p></o:p></li><li class="xmsolistparagraph" style="margin-top:0cm;margin-bottom:0cm;margin-bottom:.0001pt;line-height:115%;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">effective treatment delivery</span><o:p></o:p></li><li class="xmsolistparagraph" style="margin-top:0cm;margin-bottom:0cm;margin-bottom:.0001pt;line-height:115%;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">disease modelling</span><o:p></o:p></li><li class="xmsolistparagraph" style="margin-top:0cm;margin-bottom:0cm;margin-bottom:.0001pt;line-height:115%;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">dormancy</span><o:p></o:p></li><li class="xmsolistparagraph" style="margin-top:0cm;margin-bottom:0cm;margin-bottom:.0001pt;line-height:115%;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">high stromal content</span><o:p></o:p></li><li class="xmsolistparagraph" style="margin-top:0cm;margin-bottom:0cm;margin-bottom:.0001pt;line-height:115%;mso-list:l0 level1 lfo3">
<span style="font-family:"Arial",sans-serif">treatment resistance</span><o:p></o:p></li></ul>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif"> </span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif">We welcome applications from academia and industry.
</span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif"> </span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif">The deadline for applications to attend is
<b>8 November 2022</b>, submitted via a short online form (Survey Monkey) linked from the ‘Start application’ button in the
<a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.ukri.org%2Fopportunity%2Ftechnological-innovation-for-understanding-cancers-of-unmet-need%2F&data=05%7C01%7Ccath.cheshire%40strath.ac.uk%7C5a6c2280781e482273d108daac3ec8d3%7C631e0763153347eba5cd0457bee5944e%7C0%7C0%7C638011682890378441%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=mzhFLbjZtg8wmpR2YHNz0dOtjUv2JV95NlH7Jj%2BPc7c%3D&reserved=0">
funding opportunity listing</a> on UKRI Funding Finder. </span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif"> </span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif">The two day in person sandpit workshop will be held on 18 and 19 January 2023 in Manchester, with a pre-event online introductory meeting on 11 January 2023.
</span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif"> </span><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif">Please direct enquiries to
</span><a href="mailto:cancersandpit@mrc.ukri.org"><span style="font-family:"Arial",sans-serif">cancersandpit@mrc.ukri.org</span></a><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif"> </span><o:p></o:p></p>
<p class="xmsonormal"> <o:p></o:p></p>
<p class="xmsonormal"><b><span style="font-family:"Arial",sans-serif">Text for social media post:</span></b><o:p></o:p></p>
<p class="xmsonormal" style="margin-bottom:12.0pt"><a name="x__Hlk116311018"><span style="font-family:"Arial",sans-serif">New funding opportunity to collaborate with researchers from diverse fields to develop technological innovations for understanding hard-to-treat
cancers. </span></a><o:p></o:p></p>
<p class="xmsonormal"><span style="font-family:"Arial",sans-serif">Apply to attend the workshop by 8 November. Find out more:
<a href="https://eur02.safelinks.protection.outlook.com/?url=https%3A%2F%2Fwww.ukri.org%2Fopportunity%2Ftechnological-innovation-for-understanding-cancers-of-unmet-need%2F&data=05%7C01%7Ccath.cheshire%40strath.ac.uk%7C5a6c2280781e482273d108daac3ec8d3%7C631e0763153347eba5cd0457bee5944e%7C0%7C0%7C638011682890534654%7CUnknown%7CTWFpbGZsb3d8eyJWIjoiMC4wLjAwMDAiLCJQIjoiV2luMzIiLCJBTiI6Ik1haWwiLCJXVCI6Mn0%3D%7C3000%7C%7C%7C&sdata=jLdAJd4pQBuajS5z%2B77abVtF82G3R2k0kAeHajFBAUc%3D&reserved=0">
Find out more</a></span><o:p></o:p></p>
<p class="xmsonormal"> <o:p></o:p></p>
<p class="xmsonormal"><o:p> </o:p></p>
</div>
</div>
</div>
</div>
</body>
</html>